Stock Groups

Heart inflammation rates higher after Moderna COVID-19 shot than Pfizer vaccine-Canada data By Reuters

[ad_1]

© Reuters. FILEPHOTO: In Gaza City on August 31, 2021, a health worker prepared a dose for the Moderna vaccine to combat the coronavirus. The move was made amid rising inoculations among Palestinians. REUTERS/Suhaib Salem

(Reuters) – Friday’s data from Canada’s Public Health Agency suggests rare cases of heart inflammation are more common than previously reported. Moderna (NASDAQ:) COVID-19 vaccine is compared to the Pfizer/BioNTech shots.

Disclaimer Fusion MediaThis website does not provide accurate and current data. CFDs are stocks, indexes or futures. The prices of Forex and CFDs are not supplied by exchanges. They are instead provided by market makers. As such, the prices might not reflect market values and could be incorrect. Fusion Media does not accept any liability for trade losses that you may incur due to the use of these data.

Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information. This includes data including charts and buy/sell signal signals. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.



[ad_2]